PTH-084 Cost-Effectiveness of Vedolizumab Compared with Infliximab, Adalimumab, and Golimumab for Treatment of Moderately-to-Severely Active Ulcerative Colitis in The United Kingdom

Gut ◽  
2016 ◽  
Vol 65 (Suppl 1) ◽  
pp. A260.2-A261 ◽  
Author(s):  
M Wilson ◽  
M Kerrigan ◽  
M Smyth ◽  
H Chevrou-Severac ◽  
A Bergman ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
United Kingdom ◽  
Cost Effectiveness ◽  
Active Ulcerative Colitis ◽  
The United Kingdom

Cost-effectiveness of vedolizumab compared with infliximab, adalimumab, and golimumab in patients with ulcerative colitis in the United Kingdom

2017 ◽  
Vol 19 (2) ◽  
pp. 229-240 ◽  
Author(s):  
Michele R. Wilson ◽  
Annika Bergman ◽  
Helene Chevrou-Severac ◽  
Ross Selby ◽  
Michael Smyth ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
United Kingdom ◽  
Cost Effectiveness ◽  
The United Kingdom

scholarly journals Cost-effectiveness of pazopanib versus sunitinib for metastatic renal cell carcinoma in the United Kingdom

PLoS ONE ◽  
2017 ◽  
Vol 12 (6) ◽  
pp. e0175920 ◽  
Author(s):  
Jordan Amdahl ◽  
Jose Diaz ◽  
Arati Sharma ◽  
Jinhee Park ◽  
David Chandiwana ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
United Kingdom ◽  
Cost Effectiveness ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
The United Kingdom
Sign in / Sign up

Export Citation Format

Share Document